LIPOID GMBH

Overview

LIPOID GMBH is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering LIPOID MCT (PH.EUR., USP); LIPOID PURIFIED SOYBEAN OIL 700 (PH.EUR., USP).

API / Drug Master Files

LIPOID GMBH holds 2 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LIPOID MCT (PH.EUR., USP)Active2009-01-06
• LIPOID PURIFIED SOYBEAN OIL 700 (PH.EUR., USP)Active2008-10-17
• LIPOID S 100Inactive2012-04-03
• LIPOID S 100 EInactive2006-04-05
• LIPOID DPPC/PG 7:3Inactive2005-09-26
• LIPOID FA 16:0Inactive2002-08-09
• LIPOID S VPC-3Inactive2002-04-17
• LIPOID PURIFIED SOYBEAN OIL (PH. EUR. USP)Inactive2002-04-16
• LIPOID TRIOLEINInactive1999-08-13
• LIPOID PG 16:0/18:1-NH4 (1-PALMITOYL-2-OLEOYL-SN-GLYCERO-3- PHOSPHATIDYL GLYCEROL AMMONIUM SALT)Inactive1998-11-30
• LIPOID PC 16:0/16:0 (1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO CHOLINE)Inactive1998-05-19
• LIPOID PG 16:0/16:0Inactive1996-10-25
• LIPOID PC 18:1/18:1Inactive1996-10-25
• LIPOID E PC (EGG PHOSPHATIDYLCHOLINE)Inactive1990-07-16

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LIPOID GMBH in our records. PharmaTek screens the full directory against live FDA enforcement data.